Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lock

Showing results (81-90 of 220) with videos related to

Pageof 22
Sort By:
Cancer Research|November 15, 1988
Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase IR S Gupta, R Gupta, B Eng, et al.
British Journal of Cancer|June 16, 2020
Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemiaAbdulmohsen M Alruwetei, Katerina Bendak, Babasaheb D Yadav, et al.
Molecular Cancer Research : MCR|August 18, 2020
Targeting TSLP-Induced Tyrosine Kinase Signaling Pathways in <i>CRLF2</i>-Rearranged Ph-like ALLKeith C S Sia, Ling Zhong, Chelsea Mayoh, et al.
Pediatric Blood & Cancer|September 10, 2014
Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing ProgramHernan Carol, Mannie M Y Fan, Troy O Harasym, et al.
Hemasphere|April 27, 2026
Pharmacological inhibition of sclerostin protects bone from B-cell acute lymphoblastic leukemia-mediated destructionVincent Kuek, Joyce Oommen, Emanuela Ferrari, et al.
Pediatric Blood & Cancer|April 24, 2019
Preclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenograftsLuke Jones, Hannah McCalmont, Kathryn Evans, et al.
Plos One|May 10, 2012
Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemiaCraig T Wallington-Beddoe, Anthony S Don, John Hewson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2000
Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosisD W Voehringer, D L Hirschberg, J Xiao, et al.
Blood|May 31, 2007
Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivoMin H Kang, Yun Hee Kang, Barbara Szymanska, et al.
Cancer Research|November 17, 2006
Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cellsVictoria W Wen, Kaida Wu, Sheik Baksh, et al.
Pageof 22

Showing results (81-90 of 220) with videos related to

Sort By:
Pageof 22
Cancer Research|November 15, 1988
Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase IR S Gupta, R Gupta, B Eng, et al.
British Journal of Cancer|June 16, 2020
Examining treatment responses of diagnostic marrow in murine xenografts to predict relapse in children with acute lymphoblastic leukaemiaAbdulmohsen M Alruwetei, Katerina Bendak, Babasaheb D Yadav, et al.
Molecular Cancer Research : MCR|August 18, 2020
Targeting TSLP-Induced Tyrosine Kinase Signaling Pathways in <i>CRLF2</i>-Rearranged Ph-like ALLKeith C S Sia, Ling Zhong, Chelsea Mayoh, et al.
Pediatric Blood & Cancer|September 10, 2014
Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing ProgramHernan Carol, Mannie M Y Fan, Troy O Harasym, et al.
Hemasphere|April 27, 2026
Pharmacological inhibition of sclerostin protects bone from B-cell acute lymphoblastic leukemia-mediated destructionVincent Kuek, Joyce Oommen, Emanuela Ferrari, et al.
Pediatric Blood & Cancer|April 24, 2019
Preclinical activity of the antibody-drug conjugate denintuzumab mafodotin (SGN-CD19A) against pediatric acute lymphoblastic leukemia xenograftsLuke Jones, Hannah McCalmont, Kathryn Evans, et al.
Plos One|May 10, 2012
Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemiaCraig T Wallington-Beddoe, Anthony S Don, John Hewson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2000
Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosisD W Voehringer, D L Hirschberg, J Xiao, et al.
Blood|May 31, 2007
Activity of vincristine, L-ASP, and dexamethasone against acute lymphoblastic leukemia is enhanced by the BH3-mimetic ABT-737 in vitro and in vivoMin H Kang, Yun Hee Kang, Barbara Szymanska, et al.
Cancer Research|November 17, 2006
Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cellsVictoria W Wen, Kaida Wu, Sheik Baksh, et al.
Pageof 22